about
5-Lipoxygenase, leukotrienes biosynthesis and potential antileukotrienic agents.Design, evaluation and structure-activity relationship studies of the AChE reactivators against organophosphorus pesticides.Structure-activity relationship of quaternary acetylcholinesterase inhibitors - outlook for early myasthenia gravis treatment.Antimycobacterial evaluation of pyrazinoic acid reversible derivatives.Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decade.Pyrazine derivatives: a patent review (June 2012 - present).Synthesis and Antimicrobial Evaluation of 6-Alkylamino-N-phenylpyrazine-2-carboxamides.Synthesis and antimycobacterial evaluation of 5-alkylamino-N-phenylpyrazine-2-carboxamides.Synthesis, antimycobacterial activity and in vitro cytotoxicity of 5-chloro-N-phenylpyrazine-2-carboxamides.Salicylanilide acetates: synthesis and antibacterial evaluation.Synthesis and antimicrobial evaluation of new 2-substituted 5,7-di-tert-butylbenzoxazoles.Indole-2-carboxamide derivatives: a patent evaluation of WO2015036412A1.Synthesis of (2E)-2-methyl-3-(4-([4-(quinolin-2-ylmethoxy)phenyl]sulfanyl)phenyl)prop-2-enoic acid (VUFB 20609) and 2-methyl-3-(4-([4-(quinolin-2-ylmethoxy)phenyl]sulfanyl)phenyl)propanoic acid (VUFB 20584) as potential antileukotrienic agents.Alkylamino derivatives of pyrazinamide: synthesis and antimycobacterial evaluation.Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.Synthesis and antimycobacterial properties of N-substituted 6-amino-5-cyanopyrazine-2-carboxamides.Mono-oxime bisquaternary acetylcholinesterase reactivators with prop-1,3-diyl linkage-Preparation, in vitro screening and molecular docking.Synthesis, antimycobacterial, antifungal and photosynthesis-inhibiting activity of chlorinated N-phenylpyrazine-2-carboxamides.Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.Preparation, in vitro evaluation and molecular modelling of pyridinium-quinolinium/isoquinolinium non-symmetrical bisquaternary cholinesterase inhibitors.Synthesis and biological activity of 5-alkyl-6-(alkylsulfanyl)- or 5-alkyl-6-(arylsulfanyl)pyrazine-2-carboxamides and corresponding thioamides.Synthesis and antimycobacterial evaluation of pyrazinamide derivatives with benzylamino substitution.Substituted 5-aroylpyrazine-2-carboxylic acid derivatives: synthesis and biological activity.N-substituted 5-amino-6-methylpyrazine-2,3-dicarbonitriles: microwave-assisted synthesis and biological properties.Vibrational spectroscopic studies and ab initio calculations of a substituted amide of pyrazine-2-carboxylic acid--C12H10ClN3O.Substituted N-phenylpyrazine-2-carboxamides, their synthesis and evaluation as herbicides and abiotic elicitors.Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase.Synthesis of a novel series of bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase.Substituted pyrazinecarboxamides: synthesis and biological evaluation.New potentially active pyrazinamide derivatives synthesized under microwave conditions.Synthesis of asymmetrical bispyridinium compounds bearing cyano-moiety and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker: preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesterase.Synthesis of a novel series of non-symmetrical bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.Spectroscopic (FT-IR, FT-Raman), first order hyperpolarizability, NBO analysis, HOMO and LUMO analysis of 5-tert-Butyl-6-chloro-N-[(4-(trifluoromethyl)phenyl]pyrazine-2-carboxamideAlkylamino derivatives of N-benzylpyrazine-2-carboxamide: synthesis and antimycobacterial evaluationSubstituted N-Benzylpyrazine-2-carboxamides: Synthesis and Biological EvaluationPyrazinecarboxamides as potential elicitors of flavonolignan and flavonoid production in Silybum marianum and Ononis arvensis cultures in vitroSynthesis and antimycobacterial evaluation of substituted pyrazinecarboxamidesPreparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage – Implications for early Myasthenia gravis treatment
P50
Q36393782-6AF2A69E-5852-4EBD-B025-13F27A2A1265Q37660998-759EEDDD-C08B-43BC-BDD7-F090FFB73085Q37719566-E8329F10-2CB6-40C2-962D-560352F8B4C9Q37954728-BE30BC2B-F263-4B94-BFEE-FD38645F7743Q38266496-94C500BD-DB20-4B1E-A96A-188874800B3CQ38293637-1624CD04-1D54-4CB4-AA21-05CC9BC5C80CQ38910270-157F51D0-0FAB-4A66-A440-403D5CB7A063Q38936430-A952F4BE-2118-41B1-94D9-899D9489DBE1Q39045527-FE083295-13F9-4417-BFAE-E82340CF3C42Q40095099-815515CB-C7E3-4169-ADED-134113069B01Q40265709-0E9816E9-FDF1-4655-9569-B4B05806FCA4Q40356370-34633D10-2FFF-4DD1-A0BF-C04A366BACFDQ40539797-50518F69-1F05-410E-BBC4-90134AF4BAC0Q42707632-93025212-3351-4AC6-BA85-A5F05E43ABFDQ42722002-1D6B1CC2-BFD0-48F2-82FF-0EDE36E5788DQ42754450-F3FD7CDE-E00D-4704-BAB3-344F50D10524Q42760217-BBFCBF54-FBCE-4983-8FB8-D1D43D310E9FQ42790376-E0BE7BCF-65E6-42A3-BFC3-EC2A7D644F9BQ43170420-247ADB34-5FCC-4259-AAA0-F63FD42B5E52Q43612984-E4FE2B39-D4AC-4C66-AB61-14ABFCE1DC1BQ43922581-6BF5028E-D80E-44A8-A506-E5220F495EC4Q44096275-DAD6C5CF-6315-4A3D-A643-B598349CF75AQ44628194-49119AC9-5B6D-4702-AFB0-835647791EBFQ45881524-48646B30-AD9B-43E4-B153-7018EBC2BAF3Q46692034-7640E8B4-70E7-4D37-8081-719FC8343836Q46765187-95C22160-5381-4B59-BA2B-3D2F659E041CQ46804369-F36EDBE4-D99E-4187-975D-1C6F465265EAQ46840644-92E4543E-B9A0-4ECB-9FA8-C55A8BD974DCQ46930090-D5EF11F2-5EB0-4801-A237-64FE58D1175AQ51430719-CEE87E1C-CBFE-490B-BE08-B791ED71B53DQ52671756-4DCDA972-AE6B-4FE5-8392-D6D0EF7367EEQ52678164-38AB851D-2885-4EF3-9B40-1F52D429814DQ52683047-FA9462B8-0511-4275-AEBF-3930E1E59722Q52683914-867BDDB9-D135-4022-9F98-F6B30442CD7DQ57160798-3A801DB0-5ABD-495E-B373-1132D3DA3D62Q59054364-972AC73B-59E2-4691-8A9C-B313AA152694Q59054580-5BB38E93-2CF3-4B01-91CA-FD50D6AC038DQ60729488-27A2E89B-7454-4515-A1C9-0BEFFA63B7DFQ61877366-0B5531F8-FE7C-4112-8762-2D62E8D93DA5Q62073273-BE27DC64-C0C2-407E-B8AA-17436BB2A0D3
P50
description
researcher ORCID 0000-0002-3864-2004
@en
wetenschapper
@nl
name
Martin Dolezal
@ast
Martin Dolezal
@en
Martin Dolezal
@es
Martin Dolezal
@nl
type
label
Martin Dolezal
@ast
Martin Dolezal
@en
Martin Dolezal
@es
Martin Dolezal
@nl
prefLabel
Martin Dolezal
@ast
Martin Dolezal
@en
Martin Dolezal
@es
Martin Dolezal
@nl
P106
P1153
7006495068
P31
P496
0000-0002-3864-2004